Fresenius Kabi Recalls Tyenne Injection Vials Over Glass Particles
Fresenius Kabi recalls one lot of Tyenne (tocilizumab-aazg) 400 mg/20 mL injection vials nationwide after glass particles were found in the product.
Nationwide Drug Recall | 12/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy